Tag: Patient decision making

According to data cited by the CDC and based on real-world studies, adults who took Paxlovid within five days of a COVID-19 diagnosis showed a significantly lower hospitalization rate than those who did not. While a powerful tool, considering whether **is it worth taking Paxlovid** requires understanding who benefits most, its potential side effects, and important drug interactions.

According to some studies, the recurrence rate of a deep vein thrombosis (DVT) can be as high as 40% within 10 years for certain patients who stop their medication. For many, this raises a pressing question: **Are you on blood thinners for life after DVT?** The simple answer is no, not for everyone; the duration of treatment is a highly personalized decision based on a careful assessment of individual risks.